Research
Education
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Center for Cellular Immunotherapies,
Perelman School of Medicine,
Parker Institute for Cancer Immunotherapy,
Center for Cellular Immunotherapies, Perelman School of Medicine
Sangya Agarwal has not added Biography.
If you are Sangya Agarwal and would like to personalize this page please email our Author Liaison for assistance.
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody.
Cancer immunology, immunotherapy : CII Dec, 2017 | Pubmed ID: 28819703
Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge.
Human vaccines & immunotherapeutics 04, 2020 | Pubmed ID: 31799896
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction.
Cancer discovery 04, 2020 | Pubmed ID: 32001516
Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19.
Cancer discovery 06, 2020 | Pubmed ID: 32303509
LFA-1 signals to promote actin polymerization and upstream migration in T cells.
Journal of cell science Sep, 2020 | Pubmed ID: 32907931
University of Pennsylvania
Sangya Agarwal*,1,2,
Nils Wellhausen*,1,2,
Bruce L. Levine1,2,
Carl H. June1,2
1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania,
2Parker Institute for Cancer Immunotherapy, University of Pennsylvania
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved